|
1
|
Zhang Y, Luo YK, Zhang MB, Li J, Li CT,
Tang J and Li JL: Values of ultrasound features and MMP-9 of
papillary thyroid carcinoma in predicting cervical lymph node
metastases. Sci Rep. 7:66702017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Šelemetjev S, Ðoric I, Paunovic I, Tatic S
and Cvejic D: Coexpressed high levels of VEGF-C and active MMP-9
are associated with lymphatic spreading and local invasiveness of
papillary thyroid carcinoma. Am J Clin Pathol. 146:594–602. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang LL, Wang Z, Cao CJ, Ke ZF, Wang F,
Wang R, Luo CQ, Lu X and Wang LT: AEG-1 associates with metastasis
in papillary thyroid cancer through upregulation of MMP2/9. Int J
Oncol. 51:812–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mazzaferri EL and Jhiang SM: Long-term
impact of initial surgical and medical therapy on papillary and
follicular thyroid cancer. Am J Med. 97:418–428. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang M, Wu W, Gao M and Fei Z:
MicroRNA-451 as a prognostic marker for diagnosis and lymph node
metastasis of papillary thyroid carcinoma. Cancer Biomark.
19:437–445. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vuong HG, Duong UN, Altibi AM, Ngo HT,
Pham TQ, Tran HM, Gandolfi G and Hassell L: A meta-analysis of
prognostic roles of molecular markers in papillary thyroid
carcinoma. Endocr Connect. 6:R8–R17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim Y, Kim MH, Jeon S, Kim J, Kim C, Bae
JS and Jung CK: Prognostic implication of histological features
associated with EHD2 expression in papillary thyroid carcinoma.
PLoS One. 12:e01747372017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castro MG, Campos LE, Rodriguez YI and
Alvarez SE: In vitro methods to study the modulation of migration
and invasion by sphingosine-1-phosphate. Methods Mol Biol.
1697:117–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Edatt L, Maurya AK, Raji G, Kunhiraman H
and Kumar SVB: MicroRNA106a regulates matrix metalloprotease 9 in a
sirtuin-1 dependent mechanism. J Cell Physiol. 233:238–248. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Q, Guo X and Choksi R: Activation of
focal adhesion kinase and Src mediates acquired sorafenib
resistance in A549 human lung adenocarcinoma xenografts. J
Pharmacol Exp Ther. 363:428–443. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou G, Peng F, Zhong Y, Chen Y, Tang M
and Li D: Rhein suppresses matrix metalloproteinase production by
regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian
carcinoma cells. Int J Oncol. 50:933–941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L and Xue GB: Catalpol suppresses
osteosarcoma cell proliferation through blocking
epithelial-mesenchymal transition (EMT) and inducing apoptosis.
Biochem Biophys Res Commun. 495:27–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lai XX, Li G, Lin B and Yang H:
Interference of Notch 1 inhibits the proliferation and invasion of
breast cancer cells: Involvement of the β-catenin signaling
pathway. Mol Med Rep. 17:2472–2478. 2018.PubMed/NCBI
|
|
14
|
Bai XY, Li S, Wang M, Li X, Yang Y, Xu Z,
Li B, Li Y, Xia K, Chen H and Wu H: Krüppel-like factor 9
down-regulates matrix metalloproteinase 9 transcription and
suppresses human breast cancer invasion. Cancer Lett. 412:224–235.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu N, Si M, Yang N, Jing Y, Fu Y, Zhao X,
Lin Z and Yang G: Overexpression of RAS-association domain family 6
(RASSF6) inhibits proliferation and tumorigenesis in hepatocellular
carcinoma cells. Oncol Res. 25:1001–1008. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Y, Chen Y, Li S, Lei Y, Xu D, Jiang N,
Zhang Y, Cao J and Ke Z: NanoVelcro-captured CTC number concomitant
with enhanced serum levels of MMP7 and MMP9 enables accurate
prediction of metastasis and poor prognosis in patients with lung
adenocarcinoma. Int J Nanomedicine. 12:6399–6412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bergers G, Brekken R, McMahon G, Vu TH,
Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and
Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic
switch during carcinogenesis. Nat Cell Biol. 2:737–744. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ucuzian AA, Gassman AA, East AT and
Greisler HP: Molecular mediators of angiogenesis. J Burn Care Res.
31:158–175. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malemud CJ: Matrix metalloproteinases
(MMPs) in health and disease: An overview. Front Biosci.
11:1696–1701. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang XZ, Cui SZ, Zeng LS, Cheng TT, Li XX,
Chi J, Wang R, Zheng XF and Wang HY: Overexpression of Rab1B and
MMP9 predicts poor survival and good response to chemotherapy in
patients with colorectal cancer. Aging (Albany NY). 9:914–931.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue Q, Cao L, Chen XY, Zhao J, Gao L, Li
SZ and Fei Z: High expression of MMP9 in glioma affects cell
proliferation and is associated with patient survival rates. Oncol
Lett. 13:1325–1330. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo D, Chen H, Li X, Lu P, Long M, Peng X,
Lin S, Tan L, Zhu Y, Ouyang N and Li H: Activation of the
ROCK1/MMP-9 pathway is associated with the invasion and poor
prognosis in papillary thyroid carcinoma. Int J Oncol.
51:1209–1218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang N, Jiang R, Yang JY, Tang C, Yang L,
Xu M, Jiang QF and Liu ZM: Expression of TGF-β1, SNAI1 and MMP-9 is
associated with lymph node metastasis in papillary thyroid
carcinoma. J Mol Histol. 45:391–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng XY, Zhang Q, Li Q, Lin S and Li J:
Immunohistochemical levels of cyclo-oxygenase-2, matrix
metalloproteinase-9 and vascular endothelial growth factor in
papillary thyroid carcinoma and their clinicopathological
correlations. J Int Med Res. 42:619–627. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JJ, Wang TY, Liu CL, Chien MN, Chen
MJ, Hsu YC, Leung CH and Cheng SP: Dipeptidyl peptidase IV as a
prognostic marker and therapeutic target in papillary thyroid
carcinoma. J Clin Endocrinol Metab. 102:2930–2940. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pang L, Zhang N, Xia Y, Wang D, Wang G and
Meng X: Serum APN/CD13 as a novel diagnostic and prognostic
biomarker of pancreatic cancer. Oncotarget. 7:77854–77864. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun XF, Shao YB, Liu MG, Chen Q, Liu ZJ,
Xu B, Luo SX and Liu H: High-concentration glucose enhances
invasion in invasive ductal breast carcinoma by promoting
Glut1/MMP2/MMP9 axis expression. Oncol Lett. 13:2989–2995. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou G, Peng F, Zhong Y, Chen Y, Tang M
and Li D: Rhein suppresses matrix metalloproteinase production by
regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian
carcinoma cells. Int J Oncol. 50:933–941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu N, Si M, Yang N, Jing Y, Fu Y, Zhao X,
Lin Z and Yang G: Overexpression of RAS-association domain family 6
(RASSF6) inhibits proliferation and tumorigenesis in hepatocellular
carcinoma cells. Oncol Res. 25:1001–1008. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu B, Yang J, Zhang P, Shen L, Li X and
Li J: Safety and effectiveness of localized lung resection combined
with neoadjuvant chemotherapy in the treatment of stage I–II
non-small cell lung cancer. Oncol Lett. 13:2344–2348. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang R, Zhao J, Xu J, Jiao DX, Wang J,
Gong ZQ and Jia JH: Andrographolide suppresses proliferation of
human colon cancer SW620 cells through the TLR4/NF-κB/MMP-9
signaling pathway. Oncol Lett. 14:4305–4310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ricci S, Guadagno E, Bruzzese D, Del Basso
De Caro M, Peca C, Sgulò FG, Maiuri F and Di Carlo A: Evaluation of
matrix metalloproteinase type IV-collagenases in serum of patients
with tumors of the central nervous system. J Neurooncol.
131:223–232. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reiner AT, Tan S, Agreiter C, Auer K,
Bachmayr-Heyda A, Aust S, Pecha N, Mandorfer M, Pils D, Brisson AR,
et al: EV-associated MMP9 in high-grade serous ovarian cancer is
preferentially localized to annexin V-binding EVs. Dis Markers.
2017:96531942017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Skerenova M, Mikulova V, Capoun O, Zima T
and Tesarova P: Circulating tumor cells and serum levels of MMP-2,
MMP-9 and VEGF as markers of the metastatic process in patients
with high risk of metastatic progression. Biomed Pap Med Fac Univ
Palacky Olomouc Czech Repub. 161:272–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang J, Shing Y, Wiederschain D, Yan L,
Butterfield C, Jackson G, Harper J, Tamvakopoulos G and Moses MA:
Matrix metalloproteinase-2 is required for the switch to the
angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA.
97:3884–3889. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He J, Shen N and Huang X: Thyroid
carcinoma cells produce PLGF to enhance metastasis. Tumour Biol.
36:8601–8607. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu Q and Stamenkovic I: Cell
surface-localized matrix metalloproteinase-9 proteolytically
activates TGF-beta and promotes tumor invasion and angiogenesis.
Genes Dev. 14:163–176. 2000.PubMed/NCBI
|
|
39
|
Chang C and Werb Z: The many faces of
metalloproteases: Cell growth, invasion, angiogenesis and
metastasis. Trends Cell Biol. 11:S37–S43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zheng H and Liu JF: Studies on the
relationship between P13K/AKT signal pathway-mediated MMP-9 gene
and lung cancer. Eur Rev Med Pharmacol Sci. 21:753–759.
2017.PubMed/NCBI
|
|
41
|
Deryugina EI and Quigley JP: Tumor
angiogenesis: MMP-mediated induction of intravasation- and
metastasis-sustaining neovasculature. Matrix Biol. 44–46. 94–112.
2015.
|
|
42
|
Wu XL, Xue J, Wang LK, Yang DD, Qu M, Guo
F, Sun GY, Han L and Yang RM: Expressions of inhibitors of DNA
binding-1 and matrix metalloproteinase-9 in colorectal
adenocarcinoma tissues and their correlations with microvessel
density. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 38:696–701.
2016.PubMed/NCBI
|
|
43
|
Bai X, Li YY, Zhang HY, Wang F, He HL, Yao
JC, Liu L and Li SS: Role of matrix metalloproteinase-9 in
transforming growth factor-β1-induced epithelial-mesenchymal
transition in esophageal squamous cell carcinoma. Onco Targets
Ther. 10:2837–2847. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu XM and Sun WF: Association between
matrix metalloproteinases polymorphisms and ovarian cancer risk: A
meta-analysis and systematic review. PLoS One. 12:e01854562017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hsu CC, Huang SF, Wang JS, Chu WK, Nien
JE, Chen WS and Chow SE: Interplay of N-cadherin and matrix
metalloproteinase 9 enhances human nasopharyngeal carcinoma cell
invasion. BMC Cancer. 16:8002016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rašić I, Rašić A, Akšamija G, Radović S
and Šehović N: The association between the serum levels of matrix
metalloproteinase 9 and colorectal cancer. Med Glas (Zenica).
14:229–235. 2017.PubMed/NCBI
|
|
47
|
Li H, Qiu Z, Li F and Wang C: The
relationship between MMP-2 and MMP-9 expression levels with breast
cancer incidence and prognosis. Oncol Lett. 14:5865–5870.
2017.PubMed/NCBI
|
|
48
|
Lee CY, Shim HS, Lee S, Lee JG, Kim DJ and
Chung KY: Prognostic effect of matrix metalloproteinase-9 in
patients with resected non small cell lung cancer. J Cardiothorac
Surg. 10:442015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
He J, Liu G, Shao K, Shen X and Chen L:
Serum contents of matrix metalloproteinase-2 and 9 are correlated
with the prognosis of papillary thyroid carcinoma after
ultrasound-guided radiofrequency ablation. Biomed Res.
28:6711–6716. 2017.
|
|
50
|
Lin CM, Zeng YL, Xiao M, Mei XQ, Shen LY,
Guo MX, Lin ZY, Liu QF and Yang T: The relationship between MMP-2
−1306C>T and MMP-9-1562C>T polymorphisms and the risk and
prognosis of T-cell acute lymphoblastic leukemia in a chinese
population: A case-control study. Cell Physiol Biochem.
42:1458–1468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Aschebrook-Kilfoy B, Ward MH, Sabra MM and
Devesa SS: Thyroid cancer incidence patterns in the United States
by histologic type, 1992–2006. Thyroid. 21:125–134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yan HX, Pang P, Wang FL, Tian W, Luo YK,
Huang W, Yang GQ, Jin N, Zang L, Du J, et al: Dynamic profile of
differentiated thyroid cancer in male and female patients with
thyroidectomy during 2000–2013 in China: A retrospective study. Sci
Rep. 7:158322017. View Article : Google Scholar : PubMed/NCBI
|
